On 7 October 2025, WHO will convene a webinar to officially launch the Rapid diagnostic test accessibility considerations for professional use and self-tests, a new WHO publication which is the first of its kind to provide concrete recommendations for manufacturers to advance health equity for persons with disabilities.
Background
In the last few decades, rapid diagnostic tests, such as those for HIV, or SARS-CoV-2 (COVID-19), have become widespread in laboratories, clinics, pharmacies, and homes around the world. However, millions of people around the global still experience significant barriers in obtaining and effectively using them. People often face challenges with small or difficult to read fonts, confusing symbols, or physical difficulties with the test kit. These accessibility issues can affect everyone but can have a more serious impact on the health outcomes of millions of persons with disabilities, older adults and other marginalised populations.
Objective
The online launch of the Rapid diagnostic test accessibility considerations for professional use and self-tests will introduce this new WHO publication. You will hear from experts in different fields, including WHO, bilateral agencies, manufacturers and civil society, on the importance of making diagnostics accessible for everyone.
Date and time
The webinar will be hosted on 7 October 2025 at 2-3pm CET, which is equivalent to 8-9am EST.
Languages and accessibility
The webinar will be conducted in English with captioning and interpretation in International Sign Language.
We are committed to making this event accessible and inclusive for all participants. Upon registration, you will be asked if you require any further accommodation or support to fully participate in this webinar.
More information about the agenda and speakers will be published soon on this webpage.
/noncommunicable-diseases-rehabilitation-and-disability-(ncd)/sensory-functions-disability-and-rehabilitation-(sdr)/cover-of-the-who-rapid-diagnostic-test-accessibility-considerations.png?sfvrsn=371a3f6_4 "Cover of the WHO Rapid diagnostic test accessibility considerations")